213Bi (alpha-emitter)-antibody targeting of breast cancer metastases in the neu-N transgenic mouse model
about
Development of computational small animal models and their applications in preclinical imaging and therapy researchAn overview of targeted alpha therapy.Immunoliposomal delivery of 213Bi for alpha-emitter targeting of metastatic breast cancer.Radioimmunotherapy with α-particle-emitting radionuclides.Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb.Imaging, Biodistribution, and Dosimetry of Radionuclide-Labeled PD-L1 Antibody in an Immunocompetent Mouse Model of Breast Cancer.An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer.Emerging trends for radioimmunotherapy in solid tumorsTargeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibody.Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and TherapyRadioimmunotherapy of solid tumors: searching for the right target.Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer modelRedefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.Relevance of radiobiological concepts in radionuclide therapy of cancer.B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models.A proposed methodology to select radioisotopes for use in radionuclide therapy.Radioimmunotherapy of infection with Bi-labeled antibodiesBifunctional phage-based pretargeted imaging of human prostate carcinoma.A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry.Human HER2 overexpressing mouse breast cancer cell lines derived from MMTV.f.HuHER2 mice: characterization and use in a model of metastatic breast cancer.Imaging of Programmed Cell Death Ligand 1: Impact of Protein Concentration on Distribution of Anti-PD-L1 SPECT Agents in an Immunocompetent Murine Model of Melanoma.212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models.
P2860
Q28071642-06CD69E7-31DC-47E4-B3B9-8543511F4A94Q34238513-DB54B974-EB2E-4F2F-9852-6DC4FF6BE30DQ34296503-D25684BF-CDA8-470A-B24F-80E78C6ABF0CQ34419562-1583E35A-65BC-4006-9B80-B3DCE1D728AFQ34903258-39D4237B-D986-43FA-999E-793F23848831Q36471252-CC06D4B5-17DC-4F1E-8D73-6A0E648C2F66Q36942958-26FC0BF4-504E-40A4-A3C3-7EED64CF8A90Q37222795-A4D6FB4C-98C8-48BB-8FE2-4FA7BDDAC6A4Q37244880-1FEAD0A5-C446-4825-9CB6-FA2292E56285Q37460994-52A51A4E-19C9-4C5E-B6C0-20AEED416697Q37689802-731DF101-7174-41E4-B730-D1362382176AQ37804904-545B9272-256D-48D0-81D0-38FA5E6A7410Q38672855-FEFA75D0-DDA9-4EBA-97B4-22C9CF5EDFE1Q38724752-829F432E-ADCE-47BE-9264-F699D56BD834Q38751028-514831DD-2637-495F-A485-5192C07F790CQ38768316-A9B0E9AF-04EC-4E24-8349-6C999DF9633BQ39300127-614BBBE0-70E1-497C-8E4E-5D6F626DFF6AQ39557992-D36A4597-A3DE-4179-95D4-C2B7536E7089Q39805831-1E92C313-8112-4C8E-9B50-694191DDFA2AQ40254341-1DC1ED83-2064-4959-A800-28B30521F04FQ41776636-5F3DF94E-CD9E-4375-88F0-F181D4A1EE86Q50636979-57718DED-81BF-45F6-806A-639E7BBDB9F8Q55042518-FE94CBBF-3715-446D-A046-4D1341DBEF7C
P2860
213Bi (alpha-emitter)-antibody targeting of breast cancer metastases in the neu-N transgenic mouse model
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
213Bi (alpha-emitter)-antibody ...... e neu-N transgenic mouse model
@ast
213Bi (alpha-emitter)-antibody ...... e neu-N transgenic mouse model
@en
213Bi
@nl
type
label
213Bi (alpha-emitter)-antibody ...... e neu-N transgenic mouse model
@ast
213Bi (alpha-emitter)-antibody ...... e neu-N transgenic mouse model
@en
213Bi
@nl
prefLabel
213Bi (alpha-emitter)-antibody ...... e neu-N transgenic mouse model
@ast
213Bi (alpha-emitter)-antibody ...... e neu-N transgenic mouse model
@en
213Bi
@nl
P2093
P2860
P1433
P1476
213Bi (alpha-emitter)-antibody ...... e neu-N transgenic mouse model
@en
P2093
Alfred Morgenstern
Alyson Liedy
Caroline Esaias
Christos Apostolidis
David L Huso
Karineh Shahverdi
R Todd Reilly
P2860
P304
P356
10.1158/0008-5472.CAN-07-6308
P407
P577
2008-05-01T00:00:00Z